Concepedia

Reem Ghinnagow

RG

4

Publications

170

Citations

4

H-Index

2014

Active since

Affiliations

Inserm(Current)

Centre National de la Recherche Scientifique

Leiden University Medical Center

Institut Pasteur de Lille

Université de Lille

Reem Ghinnagow is an author at Inserm specializing in tumor immunity, immune cell therapy, and t cell immunity.

Top concepts

Publications per year

2014–2022

4

Publications

4

Targeted Delivery of α-Galactosylceramide to CD8α+ Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses

Elodie Macho-Fernandez, Luis J. Cruz, Reem Ghinnagow et al. · The Journal of Immunology · 2014 · 87 citations · Full text

, , +17

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses

Reem Ghinnagow, Julie De Meester, Luis J. Cruz et al. · OncoImmunology · 2017 · 46 citations · Full text

Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice

Jing Huang, Jing Zhou, Reem Ghinnagow et al. · Frontiers in Immunology · 2020 · 25 citations · Full text

Pseudomonas Aeruginosa Lung Infection Subverts Lymphocytic Responses through IL-23 and IL-22 Post-Transcriptional Regulation

Bérengère Villeret, Reem Ghinnagow, Saadé Kheir et al. · International Journal of Molecular Sciences · 2022 · 12 citations · Full text

Rows per page

1–4 of 4